Whole Shine Medical Technology Co Ltd

Chart & Performance

D1W1MN

P/E

—

P/S

3.06

EPS

—

Div Yield, %

1.09%

Shrs. gr., 5y

-1.82%

Rev. gr., 5y

12.37%

Revenues

757m

+51.15%

Net income

CFO

137m

+324.94%

Dividend

Mar 23, 20151 CNY/sh

Earnings

May 20, 2025

Profile

Rongyu Group Co., Ltd. engages in electrical equipment, credit investigation big data, and banking businesses in China. The company offers electrical equipment products, such as electronic control complete sets, permanent magnet low and high voltage switch products, and electronic energy meters, as well as automatic control system integration services; and credit investigation services. It also provides banking services comprising corporate finance, personal finance, and small and micro finance, as well as financial markets and international banking services; and equipment leasing, real estate leasing, and land use right leasing services. The company was formerly known as Jilin Yongda Group Co., Ltd. and changed its name to Rongyu Group Co., Ltd. in November 2016. Rongyu Group Co., Ltd. was founded in 1986 and is based in Beijing, China.

URL

http://www.wholeshinemedical.com/

IPO date

Oct 18, 2011

Employees

Domiciled in

Incorporated in

Valuation

Order:

Title CNY in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY	FY	FY
Title CNY in thousands, except ratios and share amounts	2023‑12	2022‑12	2021‑12	2020‑12	2019‑12	2018‑12	2017‑12	2016‑12	2015‑12
Income
Revenues	756,710 51.15%	500,650 197.82%
Cost of revenue	571,337	459,953
Unusual Expense (Income)
NOPBT	185,373	40,697
NOPBT Margin	24.50%	8.13%
Operating Taxes	4,146
Tax Rate	2.24%
NOPAT	181,227	40,697
Net income
Dividends	(25,370)	(22,637)
Dividend yield	0.92%	0.73%
Proceeds from repurchase of equity
BB yield
Debt
Debt current	298,936	314,879
Long-term debt	322,687	317,021
Deferred revenue	9,109	9,556
Other long-term liabilities	1	36
Net debt	(13,046)	(96,303)
Cash flow
Cash from operating activities	137,022	32,245
CAPEX	(33,626)
Cash from investing activities	(11,947)	41,423
Cash from financing activities	(101,386)
FCF	214,164	263,676
Balance
Cash	147,103	123,508
Long term investments	487,566	604,695
Excess cash	596,833	703,171
Stockholders' equity	454,241	840,000
Invested Capital	480,290	378,699
ROIC	42.20%	7.76%
ROCE	19.66%	3.73%
EV
Common stock shares outstanding	840,295	840,000
Price	3.27 -11.62%	3.70 -15.91%
Market cap	2,747,764 -11.59%	3,108,000 -15.91%
EV	2,767,077	3,051,420
EBITDA	262,784	104,048
EV/EBITDA	10.53	29.33
Interest	48,077	62,599
Interest/NOPBT	25.94%	153.82%